Ekspresi Interleukin-5 pada Polip Hidung
DAFTAR PUSTAKA
Ahmad, M.J. and Ayeh, S., 2012. The epidemiological and clinical aspects
of
nasal
polyps
that
require
surgery,
Irian
Journal
of
Otorhinolaryngology. 24(2), pp. 75-78.
Arif, M.M., Suheryanto, R., Lukmantya, dan
Anita, K.W., 2014. Kadar
reseptor glikokortikoid α dan β pada polip hidung tipe eosinofilik dan
tipe neutrofilik. ORLI, 44(2), hlm. 111-21.
Assanasen, P., and Naclerio, R.M., 2001. Medical and Nasal surgical
management of nasal Polyps. Current opinion in Otolaryngology and
Head and Neck Surgery, 9 ,pp. 27-36.
Bachert, C. and Robillard, T., 2005. Management of nasal polyposis. BENT, 1, pp: 77-86.
Bachert, C., Gevaert, P., Holtappels, G., Cuvelier, C., Cauwenberge, P.V.,
2000. Nasal Polyposis: From Cytokines to Growth. American Journal
of Rhinology, 14, pp. 279 -281.
Bachert, C., Watelet, J.B., Gevaert, P., and Cauwenberge, P.V., 2005.
Pharmacological Management of Nasal Polyposis. Journal of
Drugs,11, pp. 1537-52.
Banerji, A., Piccirillo, J.F., Thawley, S.E., Levit, R.G., Schectman, K.B.,
Kramper, A.A. & Hamiltos, D.L., 2007. Chronic rhinosinusitis patients
with polyps or polypoid mucosa have a greater burden illness.
American Journal of Rhinology, 21(1), pp: 19-26.
Baratawidjaja, K.G. dan Rengganis, I., 2012. Sitokin, in : imunologi dasar,
10th. Ed, Balai Penerbit FK-UI, Jakarta, hlm.226-8.
Bozdemir, K., Tarlak, B., Cakar, H., Doblan, A., and Kutluhan, A., 2012.
Histopathologic Evaluation of the Effects of Systemic MethylPrednisolone Treatment on Eosinophilic Nasal Polyposis. Journal of
KBB Forum, 3, pp. 40-44.
Dafale, S.R.,Yenni, V.V., Bannur, H.B., Malur, P.R., Hundgund, B.R., and
Patil, S.Y., 2012. Histopathological study of polypoidal lesions of the
46
Universitas Sumatera Utara
47
nasal cavity- A cross sectional study. Al Ameen J Med Sci, 4, pp.
403-406.
David, W.J., Côté and Wright,E.D., 2011. Objective Outcomes in
Endoscopic
Sinus
Surgery
in
:
Advances
in
Endoscopic
Surgery,pp.3-70
Delagranda, A., Gilbert-Dussardier, B., Burg, S., Allano, G., GohlerDesmonts, C., Lebreton, J.P., Dufour, X., Klossek, J.M., 2008. Nasal
polyposis: is there an inheritance pattern?A single family study.
Rhinology, 46, pp: 125-130.
Dewi, F., 2011. Profil Polip Nasi di RSUP H. Adam Malik Medan Tahun
2010, Tesis Spesialis, Universitas Sumatera Utara, Medan.
Ferguson,
B.J.,
and
Orlandi,
R.R.,
2006.
Chronic
Hypertrophic
Rhinosinusitis and Nasal Polyposis, in BJ, Bailey & JT Jonson, Head
& Neck Surgery Otolaryngology, 4th ed, Lippincot Williams & Wilkins,
Philadelphia.
Fokkens, W., Lund, V., Mullol, J.,
2007. European Position Paper on
Rhinosinusitis and Nasal Polyps (EP3OS).
Gevaert, P., Cauwenberge, P.V., and Bachert, C., 2004. Nasal Polyposis:
An Eosinophil-Mediated Disease, Thesis, Ghent University Hospital,
Belgium.
Gavaert, P., Bruaene, N.V., Cattaert, T., Steen, K.V., Zele, T.V., Acke F.,
Ruyck, N.D., Blomme, K., Sousa, A.R., Marshall, R.P., and Bachert,
C., 2011. Mepolizumab, a humanized anti–IL-5 mAb, as a treatment
option for severe nasal polyposis. J Allergy Clin Immunol, 128, pp :
989-95
Haro, J.I., Gavioli, F., Junior, V.M., and Crespo, C.C., 2009. Clinical
aspects of patients with nasal polyps. Intl. Arch. Otorhinolaryngol,
13(3), pp. 259-263.
Hasalaa, H., 2006. Role of Histamin in the Regulation of Human
Eosinophils Apoptosis. Tampereen Yliopistopaino Oy-Juvenes print.
Hasalaa, H., Giembyczb, M. A., Janka-Junttilaa,
M., Moilanena, E.,
Kankaanrantaa, H., 2008. Histamine reverses IL-5-afforded human
Universitas Sumatera Utara
48
eosinophil survival by inducing apoptosis: Pharmacological evidence
for a novel mechanism of action of histamine.
Pulmonary
Pharmacology & Therapeutics, 21, pp: 222–233.
Hellquist, H.B., 1996. Histopathology. Journal of Allergy and Asthma, 5,
pp. 237-240.
Hirschberg, A., Jókúti, A., Darvas, Z., Almay, K., Répássy, G., Falus, A.,
2003. The pathogenesis of nasal polyposis by immunoglobulin E and
interleukin-5 is completed by transforming growth factor-beta1.
Laryngoscope,113(1), pp.120-4.
Hsu, Y.C., Kuo, W.R., Chen, Y.Y., Tai, C.F., Tsai, C.J., Wang, L.F., 2007.
Increased expression of hypoxia-inducible factor 1α in nasal polyps.
American Journal of Otolaryngology Head Neck Medicine And
Surgery, 28, pp.379-383.
Indrawati, L.P.L., Pertiwi, A.N.S., Choiridah, L., dan Herwindo, B., 2012,
Gambaran Histopatologi Polip Hidung di Bagian THT-KL RS DR.
SARDJITO
2011,
Karangan
Asli,
Universitas
Gadjah
Mada,
Yogyakarta.
Irfan, M., and Shamim, A.K., 2009. Routine Histological Examination for
Nasal Polyp Specimens: Is it Necessary?. Med J Malaysia,1, pp. 5960.
Jareoncharsri, P., Bunnaag, C., Muangsomboon, S., Tunsuriyawong, D.,
Assasenan, P., 2002. Clinical and Histopathological Classilication of
nasal polyps in Thais. Siriraj Hosp Gaz, 54(11), pp. 689-697.
Johansson, L., Akerlund, A., Melen, I., Holmberg, K., and Bende, M.,
2003. Prevalence of Nasal Polyps in Adult. The Annals of Otology,
Rhinology & Laryngology, 112, pp. 625.
Jόkύti, A., 2008. Studying histamine, IL-5, IgE and TGF-beta1 in the
pathogenesis of nasal polyposis, Thesis, Semmelweis University,
Budapest.
Jonathan corren 2012. “ Inhibition of interleukin-5 for the threatment of
eosinophilic.” Discov med 13 (71) 305-312 April 2012.
Universitas Sumatera Utara
49
Kim, S.J., Lee, K.H., Kim, S.W., Cho, J.S., Park, Y.K., Shin, S.Y., 2013.
Changes in histological features of nasal polyps in a Korean
population over a 17 years periode. Otolaryngol Head Neck Surg,
149, pp.431-7.
Kirtsreesakul, V., 2005. Update on Nasal Polyps: Etiopatogenesis. Journal
Medical Association Thailand, 12, pp. 1966-1972.
Kramer, M.F. and Rasp, G., 1999. Nasal Polyposis: eosinophils and
interleukin-5. Journal of allergy, 54, pp. 669-680.
Lacroix, J.S., Zheng, C.G., Goytom, S.H., Landis, B., Szalay-Quinodoz, I.,
Malis, D.D., 2002. Histological comparison of nasal polyposis in black
African, Chinese and Caucasian patients. Rhinology, 40, pp.118-121.
Lipman, N.S., Jackson, L.R., Trudel, L.J. and Garcia, F.W., 2015.
Monoclonal
Versus
Polyclonal
Antibodies:
Distinguishing
Characteristics, Applications, and Information Resources. ILAR
Journal, 46(3), pp. 258-68.
Lund, V.J., 1995. Diagnosis and treatment of nasal polyps. British Medical
Journal, 31, pp. 1411-1414.
Lund, V.J. and Kennedy, D.W., 1995. Quantification for Staging Sinusitis.
American Journal Otol Rhinol Laryngol Suppl, 167, pp. 17-21.
Mahdavinia, M., Suh, L.A., Carter, R.G., Steven, W.W., Norton, J.E., Kato,
A., Tan, B.K., Kern, R.C., Conley, D.B., Chandra, R., Lavin, J., Peter,
A.T.,
Grammer,
L.C.,
Schleimer,
R.P.,
2015.
Increased
noneosinophilic nasal polyps in chronic rhinosinusitis in US secondgeneration Asian ssuggest genetic regulation of eosinophilia.
J
Allergy Clin Immunol, 135 (2),pp. 576-79.
Matos, L.L., Trufelli, D.C., Matos, M.G.L. and Pinhal, M.A.S., 2010.
Immunohistochemistry as an Important Tool in Biomarkers Detection
and Clinical Practice. Biomarker Insights, 5, pp. 9–20
Munir, D., 2008. Histopathology Types of Polyposis in Adam Malik
Hospital. Majalah Kedokteran Nusantara, 1, hlm. 1-3.
Mudassir, A. A. And Punagi, A., 2012. Analisis Kadar Malondialdehid
(Mda) Plasma Penderita Polip Hidung Berdasarkan Dominasi Sel
Universitas Sumatera Utara
50
Inflamasi Pada Pemeriksaan Histopatologi. Bagian Ilmu Kesehatan
Telinga Hidung Tenggorok – Kepala Leher Fakultas Kedokteran
Universitas Hasanuddin, Makassar.
Mygind, N. and Lildholdt, T., 1996. Nasal Polyps Treatment: Medical
Management. American Journal of Allergy and Asthma, 17, pp. 275280.
Mygind, N., Dahl, R., and Bachert, C., 2000. Nasal polyposis, eosinophil
dominated inflammation, and allergy. Journal of Thorax, 2, pp. S79S83.
Nagel, P. and Gürkov, R., 2009. Anatomi Hidung dan Sinus Paranasal’
dalam: Dasar-dasar Ilmu THT, 2, EGC, Jakarta.
Newton, J.R. and Ah-See, K.W. 2008. ”A riview of nasal polyposis.”
Therapeutic and Clinical Risk Management (2): pp: 507-512.
Pearlman, A.N., Chandra, R.K., Conley, D.B., and Kern, RC 2010.
Epidemiology of Nasal Polyps in Nasal Polyposis in T.M.Onerci and
B.J. Ferguson (eds), Springer-Verlag, Berlin Heidelberg.
PERHATI-KL, 2007. Algoritma Penatalaksanaan Polip Hidung dan Sinus
Paranasal (Dewasa) dalam: Guideline penyakit THT-KL di Indonesia.
Peric, A., Vojvodic, D., Durdevic, B.V., and Baletic, N., 2011. Eosinophilic
Inflammation In Allergic Rhinitis And Nasal Polyposis. Arh Hig Rada
Tokiskol, 62, pp. 341-348.
Peric, A., Vojvodic, D., Peric, A.V., Radulovic, V., and Miljanovic, O., 2013.
Correlation between cytokine level in nasal fluid and scored clinical
parameters in patients with nasal polyposis. Indian J Otolaryngol
Head Neck Surg, 65(2), pp.295-300.
Rizzardi, A.E., Johnson, A.T., Vogel, R.I., Pambuccian, S.E., Henriksen,
J., Skubitz, A.P., Metzger, G.J. and Schmechel, S.C., 2012.
Quantitative comparison of immunohistochemicalstaining measured
by digital image analysis versus pathologist visual scoring.
Diagnostic Pathology, 7, pp.42
Universitas Sumatera Utara
51
Rui, X., Yuan, L., Minqiang, X., Geng, X., Gehua, Z., and Shufang, W.,
2002. Concentration, distribution and expression of interleukin-5 in
human nasal polyp tissues. Chinese Medical Journal , 9, pp.1386-9.
Sembiring, E.S., 2014. Perbandingan Efektifitas Terapi Fluticasone
Furoate Semprot Hidung dan Metilprednisolon Oral pada Polip
Hidung dinilai dari Perubahan Jumlah Sel-sel Radang. Tesis
Program Pendidikan Dokter Spesialis Ilmu Kesehatan Telinga
Hidung Tenggorok Bedah Kepala Leher. FK USU.
Shaikh, A.A., Rafique, M., and Farrukh, M.S., 2014. An Experience of
Steroid in Recurrent Ethmoidal Nasal Polyps at Tertiary Care
Hospital.
Shi,
S.R.,
Liu,
C.,
Taylor,
C.R.,
2006.
Standardization
of
Immunohistochemistry for Formalin-fixed, Paraffin-embedded Tissue
Sections Based on the Antigen
Retrieval Technique:
From
Experiments to Hypothesis. J Histochem Cytochem,39, pp.741–8.
Syuhada, O., Shalini, P., Lim, W.K., Ammar, A., Hayati, S., Khairiyah, A.,
Gendeh, B.S., Noraidah, M., Salina, H., 2016. Malaysian nasal
polyps: eosinophil or neutrophil predominant. Med & Health,
11(1),pp. 56-61.
Tan, K.B. and Putti, T.C., 2007. Cyclooxigenase 2 expression in
nasopharyngeal carcinoma: Immunochemical Finding and Potential
Implications. J Clin Pathol, 58, pp.535-538
Tikaram, A. And Prepageran, N., 2013. Asian nasal polyps: a separate
entity?. Med J Malaysia, 68(6), pp.445-447.
Valera et al. 2011. “In vitro effect of glucocorticoids on nasal polyps.”
Brazilian Journal of Otorhinolaryngology , 5, pp. 605-10.
Wang, D.Y., 2008. Significance of Susceptible Gene Expression Profiles in
Nasal Polyposis. Clinical and Experimental Otorhinolaryngology,1(4),
pp.177-183.
Wardani, R.S., 2011. Profil Ekspresi Gen Penderita Polip Hidung
Kaitannya dengan Respon Terapi Terhadap Protokol Pengobatan
Universitas Sumatera Utara
52
Polipektomi Sederhana Endoskopik dan Glukokortikoid Intranasal.
Ringkasan Disertasi. FK UI.
Wu, J., Bing, L., Jin, H., and Jinping F., 2009. Gene expression profiles of
nasal polyps associatd with allergic rhinitis. American Journal of
Otolaryngology Head and Neck Medicine and Surgery, 30, pp.24-32.
Yaziji, H. and Barry, T., 2006. Diagnostic Immunohistochemistry: what can
go wrong? Adv Anat Pathol, 13, pp. 238–46.
Universitas Sumatera Utara
Ahmad, M.J. and Ayeh, S., 2012. The epidemiological and clinical aspects
of
nasal
polyps
that
require
surgery,
Irian
Journal
of
Otorhinolaryngology. 24(2), pp. 75-78.
Arif, M.M., Suheryanto, R., Lukmantya, dan
Anita, K.W., 2014. Kadar
reseptor glikokortikoid α dan β pada polip hidung tipe eosinofilik dan
tipe neutrofilik. ORLI, 44(2), hlm. 111-21.
Assanasen, P., and Naclerio, R.M., 2001. Medical and Nasal surgical
management of nasal Polyps. Current opinion in Otolaryngology and
Head and Neck Surgery, 9 ,pp. 27-36.
Bachert, C. and Robillard, T., 2005. Management of nasal polyposis. BENT, 1, pp: 77-86.
Bachert, C., Gevaert, P., Holtappels, G., Cuvelier, C., Cauwenberge, P.V.,
2000. Nasal Polyposis: From Cytokines to Growth. American Journal
of Rhinology, 14, pp. 279 -281.
Bachert, C., Watelet, J.B., Gevaert, P., and Cauwenberge, P.V., 2005.
Pharmacological Management of Nasal Polyposis. Journal of
Drugs,11, pp. 1537-52.
Banerji, A., Piccirillo, J.F., Thawley, S.E., Levit, R.G., Schectman, K.B.,
Kramper, A.A. & Hamiltos, D.L., 2007. Chronic rhinosinusitis patients
with polyps or polypoid mucosa have a greater burden illness.
American Journal of Rhinology, 21(1), pp: 19-26.
Baratawidjaja, K.G. dan Rengganis, I., 2012. Sitokin, in : imunologi dasar,
10th. Ed, Balai Penerbit FK-UI, Jakarta, hlm.226-8.
Bozdemir, K., Tarlak, B., Cakar, H., Doblan, A., and Kutluhan, A., 2012.
Histopathologic Evaluation of the Effects of Systemic MethylPrednisolone Treatment on Eosinophilic Nasal Polyposis. Journal of
KBB Forum, 3, pp. 40-44.
Dafale, S.R.,Yenni, V.V., Bannur, H.B., Malur, P.R., Hundgund, B.R., and
Patil, S.Y., 2012. Histopathological study of polypoidal lesions of the
46
Universitas Sumatera Utara
47
nasal cavity- A cross sectional study. Al Ameen J Med Sci, 4, pp.
403-406.
David, W.J., Côté and Wright,E.D., 2011. Objective Outcomes in
Endoscopic
Sinus
Surgery
in
:
Advances
in
Endoscopic
Surgery,pp.3-70
Delagranda, A., Gilbert-Dussardier, B., Burg, S., Allano, G., GohlerDesmonts, C., Lebreton, J.P., Dufour, X., Klossek, J.M., 2008. Nasal
polyposis: is there an inheritance pattern?A single family study.
Rhinology, 46, pp: 125-130.
Dewi, F., 2011. Profil Polip Nasi di RSUP H. Adam Malik Medan Tahun
2010, Tesis Spesialis, Universitas Sumatera Utara, Medan.
Ferguson,
B.J.,
and
Orlandi,
R.R.,
2006.
Chronic
Hypertrophic
Rhinosinusitis and Nasal Polyposis, in BJ, Bailey & JT Jonson, Head
& Neck Surgery Otolaryngology, 4th ed, Lippincot Williams & Wilkins,
Philadelphia.
Fokkens, W., Lund, V., Mullol, J.,
2007. European Position Paper on
Rhinosinusitis and Nasal Polyps (EP3OS).
Gevaert, P., Cauwenberge, P.V., and Bachert, C., 2004. Nasal Polyposis:
An Eosinophil-Mediated Disease, Thesis, Ghent University Hospital,
Belgium.
Gavaert, P., Bruaene, N.V., Cattaert, T., Steen, K.V., Zele, T.V., Acke F.,
Ruyck, N.D., Blomme, K., Sousa, A.R., Marshall, R.P., and Bachert,
C., 2011. Mepolizumab, a humanized anti–IL-5 mAb, as a treatment
option for severe nasal polyposis. J Allergy Clin Immunol, 128, pp :
989-95
Haro, J.I., Gavioli, F., Junior, V.M., and Crespo, C.C., 2009. Clinical
aspects of patients with nasal polyps. Intl. Arch. Otorhinolaryngol,
13(3), pp. 259-263.
Hasalaa, H., 2006. Role of Histamin in the Regulation of Human
Eosinophils Apoptosis. Tampereen Yliopistopaino Oy-Juvenes print.
Hasalaa, H., Giembyczb, M. A., Janka-Junttilaa,
M., Moilanena, E.,
Kankaanrantaa, H., 2008. Histamine reverses IL-5-afforded human
Universitas Sumatera Utara
48
eosinophil survival by inducing apoptosis: Pharmacological evidence
for a novel mechanism of action of histamine.
Pulmonary
Pharmacology & Therapeutics, 21, pp: 222–233.
Hellquist, H.B., 1996. Histopathology. Journal of Allergy and Asthma, 5,
pp. 237-240.
Hirschberg, A., Jókúti, A., Darvas, Z., Almay, K., Répássy, G., Falus, A.,
2003. The pathogenesis of nasal polyposis by immunoglobulin E and
interleukin-5 is completed by transforming growth factor-beta1.
Laryngoscope,113(1), pp.120-4.
Hsu, Y.C., Kuo, W.R., Chen, Y.Y., Tai, C.F., Tsai, C.J., Wang, L.F., 2007.
Increased expression of hypoxia-inducible factor 1α in nasal polyps.
American Journal of Otolaryngology Head Neck Medicine And
Surgery, 28, pp.379-383.
Indrawati, L.P.L., Pertiwi, A.N.S., Choiridah, L., dan Herwindo, B., 2012,
Gambaran Histopatologi Polip Hidung di Bagian THT-KL RS DR.
SARDJITO
2011,
Karangan
Asli,
Universitas
Gadjah
Mada,
Yogyakarta.
Irfan, M., and Shamim, A.K., 2009. Routine Histological Examination for
Nasal Polyp Specimens: Is it Necessary?. Med J Malaysia,1, pp. 5960.
Jareoncharsri, P., Bunnaag, C., Muangsomboon, S., Tunsuriyawong, D.,
Assasenan, P., 2002. Clinical and Histopathological Classilication of
nasal polyps in Thais. Siriraj Hosp Gaz, 54(11), pp. 689-697.
Johansson, L., Akerlund, A., Melen, I., Holmberg, K., and Bende, M.,
2003. Prevalence of Nasal Polyps in Adult. The Annals of Otology,
Rhinology & Laryngology, 112, pp. 625.
Jόkύti, A., 2008. Studying histamine, IL-5, IgE and TGF-beta1 in the
pathogenesis of nasal polyposis, Thesis, Semmelweis University,
Budapest.
Jonathan corren 2012. “ Inhibition of interleukin-5 for the threatment of
eosinophilic.” Discov med 13 (71) 305-312 April 2012.
Universitas Sumatera Utara
49
Kim, S.J., Lee, K.H., Kim, S.W., Cho, J.S., Park, Y.K., Shin, S.Y., 2013.
Changes in histological features of nasal polyps in a Korean
population over a 17 years periode. Otolaryngol Head Neck Surg,
149, pp.431-7.
Kirtsreesakul, V., 2005. Update on Nasal Polyps: Etiopatogenesis. Journal
Medical Association Thailand, 12, pp. 1966-1972.
Kramer, M.F. and Rasp, G., 1999. Nasal Polyposis: eosinophils and
interleukin-5. Journal of allergy, 54, pp. 669-680.
Lacroix, J.S., Zheng, C.G., Goytom, S.H., Landis, B., Szalay-Quinodoz, I.,
Malis, D.D., 2002. Histological comparison of nasal polyposis in black
African, Chinese and Caucasian patients. Rhinology, 40, pp.118-121.
Lipman, N.S., Jackson, L.R., Trudel, L.J. and Garcia, F.W., 2015.
Monoclonal
Versus
Polyclonal
Antibodies:
Distinguishing
Characteristics, Applications, and Information Resources. ILAR
Journal, 46(3), pp. 258-68.
Lund, V.J., 1995. Diagnosis and treatment of nasal polyps. British Medical
Journal, 31, pp. 1411-1414.
Lund, V.J. and Kennedy, D.W., 1995. Quantification for Staging Sinusitis.
American Journal Otol Rhinol Laryngol Suppl, 167, pp. 17-21.
Mahdavinia, M., Suh, L.A., Carter, R.G., Steven, W.W., Norton, J.E., Kato,
A., Tan, B.K., Kern, R.C., Conley, D.B., Chandra, R., Lavin, J., Peter,
A.T.,
Grammer,
L.C.,
Schleimer,
R.P.,
2015.
Increased
noneosinophilic nasal polyps in chronic rhinosinusitis in US secondgeneration Asian ssuggest genetic regulation of eosinophilia.
J
Allergy Clin Immunol, 135 (2),pp. 576-79.
Matos, L.L., Trufelli, D.C., Matos, M.G.L. and Pinhal, M.A.S., 2010.
Immunohistochemistry as an Important Tool in Biomarkers Detection
and Clinical Practice. Biomarker Insights, 5, pp. 9–20
Munir, D., 2008. Histopathology Types of Polyposis in Adam Malik
Hospital. Majalah Kedokteran Nusantara, 1, hlm. 1-3.
Mudassir, A. A. And Punagi, A., 2012. Analisis Kadar Malondialdehid
(Mda) Plasma Penderita Polip Hidung Berdasarkan Dominasi Sel
Universitas Sumatera Utara
50
Inflamasi Pada Pemeriksaan Histopatologi. Bagian Ilmu Kesehatan
Telinga Hidung Tenggorok – Kepala Leher Fakultas Kedokteran
Universitas Hasanuddin, Makassar.
Mygind, N. and Lildholdt, T., 1996. Nasal Polyps Treatment: Medical
Management. American Journal of Allergy and Asthma, 17, pp. 275280.
Mygind, N., Dahl, R., and Bachert, C., 2000. Nasal polyposis, eosinophil
dominated inflammation, and allergy. Journal of Thorax, 2, pp. S79S83.
Nagel, P. and Gürkov, R., 2009. Anatomi Hidung dan Sinus Paranasal’
dalam: Dasar-dasar Ilmu THT, 2, EGC, Jakarta.
Newton, J.R. and Ah-See, K.W. 2008. ”A riview of nasal polyposis.”
Therapeutic and Clinical Risk Management (2): pp: 507-512.
Pearlman, A.N., Chandra, R.K., Conley, D.B., and Kern, RC 2010.
Epidemiology of Nasal Polyps in Nasal Polyposis in T.M.Onerci and
B.J. Ferguson (eds), Springer-Verlag, Berlin Heidelberg.
PERHATI-KL, 2007. Algoritma Penatalaksanaan Polip Hidung dan Sinus
Paranasal (Dewasa) dalam: Guideline penyakit THT-KL di Indonesia.
Peric, A., Vojvodic, D., Durdevic, B.V., and Baletic, N., 2011. Eosinophilic
Inflammation In Allergic Rhinitis And Nasal Polyposis. Arh Hig Rada
Tokiskol, 62, pp. 341-348.
Peric, A., Vojvodic, D., Peric, A.V., Radulovic, V., and Miljanovic, O., 2013.
Correlation between cytokine level in nasal fluid and scored clinical
parameters in patients with nasal polyposis. Indian J Otolaryngol
Head Neck Surg, 65(2), pp.295-300.
Rizzardi, A.E., Johnson, A.T., Vogel, R.I., Pambuccian, S.E., Henriksen,
J., Skubitz, A.P., Metzger, G.J. and Schmechel, S.C., 2012.
Quantitative comparison of immunohistochemicalstaining measured
by digital image analysis versus pathologist visual scoring.
Diagnostic Pathology, 7, pp.42
Universitas Sumatera Utara
51
Rui, X., Yuan, L., Minqiang, X., Geng, X., Gehua, Z., and Shufang, W.,
2002. Concentration, distribution and expression of interleukin-5 in
human nasal polyp tissues. Chinese Medical Journal , 9, pp.1386-9.
Sembiring, E.S., 2014. Perbandingan Efektifitas Terapi Fluticasone
Furoate Semprot Hidung dan Metilprednisolon Oral pada Polip
Hidung dinilai dari Perubahan Jumlah Sel-sel Radang. Tesis
Program Pendidikan Dokter Spesialis Ilmu Kesehatan Telinga
Hidung Tenggorok Bedah Kepala Leher. FK USU.
Shaikh, A.A., Rafique, M., and Farrukh, M.S., 2014. An Experience of
Steroid in Recurrent Ethmoidal Nasal Polyps at Tertiary Care
Hospital.
Shi,
S.R.,
Liu,
C.,
Taylor,
C.R.,
2006.
Standardization
of
Immunohistochemistry for Formalin-fixed, Paraffin-embedded Tissue
Sections Based on the Antigen
Retrieval Technique:
From
Experiments to Hypothesis. J Histochem Cytochem,39, pp.741–8.
Syuhada, O., Shalini, P., Lim, W.K., Ammar, A., Hayati, S., Khairiyah, A.,
Gendeh, B.S., Noraidah, M., Salina, H., 2016. Malaysian nasal
polyps: eosinophil or neutrophil predominant. Med & Health,
11(1),pp. 56-61.
Tan, K.B. and Putti, T.C., 2007. Cyclooxigenase 2 expression in
nasopharyngeal carcinoma: Immunochemical Finding and Potential
Implications. J Clin Pathol, 58, pp.535-538
Tikaram, A. And Prepageran, N., 2013. Asian nasal polyps: a separate
entity?. Med J Malaysia, 68(6), pp.445-447.
Valera et al. 2011. “In vitro effect of glucocorticoids on nasal polyps.”
Brazilian Journal of Otorhinolaryngology , 5, pp. 605-10.
Wang, D.Y., 2008. Significance of Susceptible Gene Expression Profiles in
Nasal Polyposis. Clinical and Experimental Otorhinolaryngology,1(4),
pp.177-183.
Wardani, R.S., 2011. Profil Ekspresi Gen Penderita Polip Hidung
Kaitannya dengan Respon Terapi Terhadap Protokol Pengobatan
Universitas Sumatera Utara
52
Polipektomi Sederhana Endoskopik dan Glukokortikoid Intranasal.
Ringkasan Disertasi. FK UI.
Wu, J., Bing, L., Jin, H., and Jinping F., 2009. Gene expression profiles of
nasal polyps associatd with allergic rhinitis. American Journal of
Otolaryngology Head and Neck Medicine and Surgery, 30, pp.24-32.
Yaziji, H. and Barry, T., 2006. Diagnostic Immunohistochemistry: what can
go wrong? Adv Anat Pathol, 13, pp. 238–46.
Universitas Sumatera Utara